Actively Recruiting
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Led by CorEvitas · Updated on 2026-02-09
1500
Participants Needed
1
Research Sites
3956 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the country where the participating registry site is located.
CONDITIONS
Official Title
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with severe alopecia areata by a dermatologist or qualified dermatology provider
- Aged 12 to 17 years at enrollment
- Willing to provide consent or assent for participation
- Prescribed a new commercially available advanced or systemic therapy for severe alopecia areata within 6 months before or at enrollment
- Deemed a candidate for treatment with these therapies if not currently treated
You will not qualify if you...
- Participating or planning to participate in a blinded clinical trial for any investigational medication
- Unwilling or unable to provide standing height measurements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CorEvitas, LLC
Waltham, Massachusetts, United States, 02451
Actively Recruiting
Research Team
C
CorEvitas
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here